{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:10:16Z","timestamp":1758579016313,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002635","name":"Inha University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.transproceed.2021.10.017","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:16:28Z","timestamp":1642752988000},"page":"528-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiple Gouty Arthritis With Tophi Formation in a Patient With End-Stage Kidney Disease Treated After Kidney Transplant"],"prefix":"10.1016","volume":"54","author":[{"given":"Jin Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeryong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kipyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoung Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seun Deuk","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3138-074X","authenticated-orcid":false,"given":"Joon Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.10.017_bib0001","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/03007995.2017.1372157","article-title":"Uric acid and incident chronic kidney disease in dyslipidemic individuals","volume":"34","author":"Barkas","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0002","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.56.11.696a","article-title":"Serum uric acid in acute gout","volume":"56","author":"Logan","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0003","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9610(88)80196-X","article-title":"Hyperuricemia after renal transplantation","volume":"156","author":"Gores","year":"1988","journal-title":"Am J Surg"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198908033210504","article-title":"Cyclosporine-induced hyperuricemia and gout","volume":"321","author":"Lin","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9343(92)90104-J","article-title":"Hyperuricemia and gout among heart transplant recipients receiving cyclosporine","volume":"92","author":"Burack","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0006","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1681\/ASN.V115974","article-title":"Renal transplant-associated hyperuricemia and gout","volume":"11","author":"Clive","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0007","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.tp.0000188722.84775.af","article-title":"New-onset gout after kidney transplantation: incidence, risk factors and implications","volume":"80","author":"Abbott","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0008","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.transproceed.2019.04.050","article-title":"Gout severity in recipients of kidney transplant","volume":"51","author":"Brigham","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0009","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/j.1600-6143.2007.01977.x","article-title":"Disappearance of tophi in familial juvenile hyperuricemic nephropathy after kidney transplantation","volume":"7","author":"Merieau","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","article-title":"Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort","volume":"44","author":"Iseki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0011","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0012","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","article-title":"Relationship of uric acid with progression of kidney disease","volume":"50","author":"Chonchol","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0013","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0272-6386(99)70295-7","article-title":"Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease","volume":"33","author":"Johnson","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0014","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1440-1797.2004.00336.x","article-title":"Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed","volume":"9","author":"Kanellis","year":"2004","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semnephrol.2004.09.008","article-title":"Uric acid and transplantation","volume":"25","author":"Mazzali","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0016","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1034\/j.1399-0012.1999.130502.x","article-title":"Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients","volume":"13","author":"Gerhardt","year":"1999","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0017","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/j.ajkd.2017.06.013","article-title":"Impact of hyperuricemia on long-term outcomes of kidney transplantation: analysis of the FAVORIT study","volume":"70","author":"Kalil","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0018","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/01.tp.0000183895.88572.13","article-title":"Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients?","volume":"80","author":"Armstrong","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0019","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.transproceed.2020.01.062","article-title":"Complications of renal transplantation that influence the presence of hyperuricemia in its first year of evolution","volume":"52","author":"Cheng","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.transproceed.2018.02.127","article-title":"Kidney transplantation from old deceased donors: impact of uric acid level-a quarter-century of experience in one transplant center","volume":"50","author":"Magott-Procelewska","year":"2018","journal-title":"Transplant Proc"},{"issue":"Suppl. 1","key":"10.1016\/j.transproceed.2021.10.017_bib0021","doi-asserted-by":"crossref","first-page":"276","DOI":"10.6002\/ect.mesot2014.P112","article-title":"Dermal tophus: a complication of gout in a kidney transplant recipient","volume":"13","author":"Ayvazoglu Soy","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0022","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.27356","article-title":"Cellular characterization of the gouty tophus: a quantitative analysis","volume":"62","author":"Dalbeth","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0023","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MNH.0000000000000691","article-title":"Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum","volume":"30","author":"Premachandra","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0026","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0027","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2165\/11592290-000000000-00000","article-title":"Difficult-to-treat gouty arthritis: a disease warranting better management","volume":"71","author":"Schlesinger","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0028","doi-asserted-by":"crossref","first-page":"e13820","DOI":"10.1111\/ctr.13820","article-title":"Efficacy and safety of febuxostat for treatment of asymptomatic hyperuricemia among kidney transplant patients: a meta-analysis of observational studies","volume":"34","author":"Chewcharat","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0029","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/DDDT.S56597","article-title":"Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients","volume":"8","author":"Sofue","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jbspin.2018.03.015","article-title":"Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: a multicentre, retrospective study","volume":"85","author":"Loustau","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0031","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.920553","article-title":"A retrospective cohort study of the effect of gout on mortality among patients with a history of kidney transplantation","volume":"25","author":"Li","year":"2020","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0032","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00007890-199107000-00013","article-title":"Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use","volume":"52","author":"Noordzij","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0033","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/0971-4065.111849","article-title":"Prevalence and risk factors of hyperuricemia among kidney transplant recipients","volume":"23","author":"Einollahi","year":"2013","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.transproceed.2021.10.017_bib0034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(67)90004-6","article-title":"Epidemiology of gout and hyperuricemia. A long-term population study","volume":"42","author":"Hall","year":"1967","journal-title":"Am J Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521009131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521009131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:41:44Z","timestamp":1758577304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521009131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0041134521009131"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.10.017","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Gouty Arthritis With Tophi Formation in a Patient With End-Stage Kidney Disease Treated After Kidney Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}